Instalab

Timothy Grass (Phl p 2) IgE Test Blood

Confirm whether your grass pollen symptoms come from real allergy, not just look-alike cross-reactions.

Should you take a Timothy Grass (Phl p 2) IgE test?

This test is most useful if any of these apply to you.

Suffering Through Grass Pollen Season
If spring and summer bring congestion, itchy eyes, and wheezing, this confirms whether grass pollen is really the culprit.
Considering Allergy Shots or Tablets
Immunotherapy works best when matched to your true sensitization pattern. This test helps figure out if grass-targeted therapy fits you.
Managing Seasonal Asthma
If your asthma flares during pollen season, knowing which grass proteins drive your immune response shapes how to prevent attacks.
Confused by Inconsistent Allergy Tests
If your skin prick and blood tests disagree or come back broadly positive, this narrows down what's really driving your symptoms.

About Timothy Grass (Phl p 2) IgE

Spring and summer congestion, itchy eyes, and seasonal wheezing often get labeled as a generic grass allergy. But not every positive grass pollen test means the same thing. Some people react to the actual grass proteins. Others test positive because of look-alike molecules that show up in many plants, foods, and pollens. Knowing which group you fall into changes everything about how you treat it.

This test measures your antibody response to Phl p 2, one of the signature proteins of Timothy grass (Phleum pratense). A positive result is a marker of genuine grass pollen sensitization rather than a cross-reactive bystander signal. That distinction matters most when you are deciding whether allergy shots or sublingual tablets are likely to help.

What Phl p 2 Actually Tells You

IgE (immunoglobulin E) is the antibody class your immune system makes when it has decided a harmless protein is a threat. When you breathe in grass pollen, allergen-specific B cells switch class and produce IgE that latches onto pollen proteins. Phl p 2 is one of several individual proteins inside Timothy grass pollen that can drive this response, and it is recognized as a marker of true grass sensitization alongside Phl p 1, 4, 5, 6, and 11.

Standard grass allergy tests use a crushed-up whole pollen extract, which contains everything in the pollen including proteins that resemble molecules found in birch, weeds, and certain foods. A positive whole-extract test can come from any of those overlaps. Phl p 2 testing zooms in on a protein that is much more specific to grass itself, which is why it shows up in component-resolved allergy panels.

Who Tends to Be Positive

Phl p 2 sensitization rates vary widely by geography and by which grasses are dominant in your area. In an Italian clinic of grass-allergic patients, more than 70% were co-sensitized to Phl p 2 along with Phl p 1, 4, 5, and 6. In Brazilian grass-allergic adults, 76% had IgE to Phl p 2. In an atopic dermatitis cohort from the Czech Republic, 45% tested positive. By contrast, in a northern China study of 73 patients with timothy-pollen-specific IgE, none had detectable IgE to Phl p 2, with profilin-driven cross-reactivity dominating instead.

The takeaway: this is a regionally variable marker. If you live somewhere where temperate grasses (rye, fescue, bluegrass, Timothy) are the dominant pollen producers, Phl p 2 is more likely to be informative. In areas dominated by subtropical or weed pollens, your sensitization pattern may run through different components.

Why It Beats Whole-Extract Grass Testing

Whole grass extract IgE tests can return positive results in people who are not actually allergic to grass. In Chinese pollinosis patients, most grass-extract IgE was driven by profilins and cross-reactive carbohydrate determinants triggered by other pollens, not by genuine grass allergy. Component testing solved the ambiguity. If you have a high grass-extract reading but no IgE to Phl p 1, 2, 5, or 6, your symptoms during grass season may have a different driver entirely.

This matters for treatment. Allergy immunotherapy with grass pollen extract works best when you are sensitized to the actual grass proteins inside the vaccine. A patient whose positive test reflects cross-reactivity with weed profilin is unlikely to benefit from grass-targeted desensitization. Component patterns help match the patient to the right therapy.

The Sensitization Trajectory

Phl p 2 is typically a later arrival in the allergy timeline. Birth cohort studies show that grass allergy in children usually begins with IgE to Phl p 1 and Phl p 5, with Phl p 2 appearing later alongside Phl p 6 and 11 in a process called molecular spreading. By the time someone has IgE to several components including Phl p 2, the sensitization profile tends to be broader and more diversified.

Broader profiles are not just a curiosity. Pediatric studies link earlier and wider grass component sensitization to higher asthma risk and reduced lung function, while later-onset profiles track more with hay fever symptoms. Polysensitization to multiple allergen components has been associated with more severe rhinitis and higher asthma prevalence in adults as well.

Asthma and Rhinitis Associations

Phl p 2 IgE shows up in patients with allergic rhinitis and grass-triggered asthma. In the LEAD cohort of adult asthma patients, molecular IgE profiling that included Phl p 2 helped identify subgroups likely to benefit from allergen-based immunotherapy or biologic treatments. In a study of 100 atopic dermatitis patients, high levels of specific IgE to allergens including grass components were associated with the severity of bronchial asthma and allergic rhinitis.

A positive Phl p 2 by itself does not diagnose asthma or guarantee severe rhinitis. It tells you the immune system has primed against grass pollen, which becomes meaningful when paired with seasonal symptoms in your timeline.

Seasonal Swings in Your Number

Phl p 2 IgE is not a fixed number. In 276 grass-allergic Italian adults, the median IgE to Phl p 2 was below the standard low-detection cutoff out of season, but rose substantially during pollen season alongside total IgE and inflammation markers. If you are tested in the dead of winter your number will look much smaller than if you are tested in late spring.

This is biology, not a measurement glitch. Your immune system is responding to active exposure. The seasonal swing also tells you something useful: if your level fails to rise during peak grass season, your symptoms are probably not coming from grass.

What Immunotherapy Does to This Number

Allergen immunotherapy is the only treatment that changes the underlying immune programming behind grass allergy. Both shots (subcutaneous immunotherapy, or SCIT) and under-the-tongue tablets (sublingual immunotherapy, or SLIT) prompt your body to produce blocking antibodies (IgG4 and IgA) that neutralize allergens before they trigger IgE-driven reactions.

Effects on Phl p 2 IgE specifically are mixed. In a 2-year trial of the recombinant grass pollen vaccine BM32, Phl p 2 IgE levels did not increase despite repeated dosing, and seasonal boosts were partially blunted. In a short-term grass immunotherapy study, Phl p 2 IgE did not consistently change while blocking IgG4 to other components increased. The pattern across studies is that IgE eventually stabilizes or falls while the blocking antibodies do the protective work.

Tracking Your Trend

A single Phl p 2 IgE reading is a snapshot taken at one point in a complex seasonal cycle. Because levels fluctuate with grass exposure and decline with age, a serial pattern is more informative than any one number. Get a baseline, ideally outside of peak grass season so you have a non-stimulated reading. If you start immunotherapy, retest at 6 to 12 months to see how your antibody profile is shifting. After that, an annual check during a consistent time of year lets you watch the trajectory rather than chase the seasonal noise.

Standardized clinical cutpoints for what counts as high or low Phl p 2 do not yet exist in the way they do for cholesterol or blood sugar. Your number is most useful in two contexts: confirming genuine grass sensitization when other tests are ambiguous, and watching the direction of change over time while you are doing something about it.

When Results Can Be Misleading

A few realities to keep in mind when reading your result:

  • Season of the draw: levels rise during grass pollen season and fall outside it. A winter result and a summer result on the same person are not directly comparable.
  • Age: total and grass-specific IgE tend to drift down with age. An older adult with longstanding grass allergy may have a smaller number than a teenager with the same clinical picture.
  • Regional pollen mix: in areas where subtropical or weed pollens dominate, Phl p 2 may be negative even though you have real seasonal symptoms driven by different allergen components.
  • Active immunotherapy: while you are on grass allergy shots or tablets, your IgE pattern is being deliberately reshaped. Interpret results in the context of where you are in the treatment timeline.

What to Do With an Unexpected Result

If Phl p 2 is positive and your symptoms match grass pollen season, the next step is usually a fuller component panel that adds Phl p 1, 5, 6, 7, and 12 to define the breadth of your sensitization. An allergist or immunologist can use the combined profile to decide whether grass immunotherapy is likely to work and which formulation is best matched to your antibody pattern.

If Phl p 2 is negative but you have strong seasonal symptoms, the answer is rarely "you do not have allergies." It usually means you should look at other grass components or other pollens entirely. Skin prick testing with grass extract is also more sensitive than blood testing in some studies and may catch genuine sensitization that component panels miss. The combination of skin testing, component blood work, and a careful symptom timeline is what produces a useful answer.

What Moves This Biomarker

Evidence-backed interventions that affect your Timothy Grass (Phl p 2) IgE level

Increase
Seasonal grass pollen exposure
Active grass pollen exposure during peak season drives a real rise in your Phl p 2 IgE. In 276 Italian grass-allergic patients, median Phl p 2 IgE was below the lab's low-detection threshold out of season and rose substantially during pollen season, alongside total IgE and eosinophil activation markers. The change reflects ongoing immune activation, not just a lab fluctuation.
LifestyleStrong Evidence
Up & Down
Grass pollen allergy shots (subcutaneous immunotherapy)
Allergy shots reshape your antibody response over months to years. In a study of 22 grass-allergic patients undergoing hyposensitization, IgE and IgG4 to Phl p 2 and other Timothy grass components shifted in patterns that depended on the extract used. The clinical goal is not to drive Phl p 2 IgE to zero but to induce blocking IgG4 antibodies that neutralize allergen before it triggers reactions, while specific IgE eventually stabilizes or falls.
MedicationModerate Evidence
Up & Down
Sublingual immunotherapy tablets (Timothy grass)
Daily under-the-tongue Timothy grass tablets induce IgA and IgG blocking antibodies and gradually modulate IgE response. In a pooled analysis of 21,045 patients, higher baseline Timothy grass-specific IgE predicted greater treatment efficacy as well as more treatment-related side effects. Effects on Phl p 2 IgE specifically include early stabilization followed by long-term shifts as blocking antibodies build up.
MedicationModerate Evidence
Decrease
Recombinant grass pollen vaccine (BM32)
An experimental recombinant grass vaccine reshapes the immune response without provoking new IgE. In a 2-year randomized trial of 40 patients, Phl p 2 IgE levels in serum did not increase despite repeated vaccination, and the typical seasonal rise in grass-specific IgE was partially blunted. Continuously increasing IgG4 over two years appears to explain higher clinical efficacy in year two.
MedicationModerate Evidence

Frequently Asked Questions

References

21 studies
  1. Rossi R, Monasterolo G, Prina P, Coco G, Operti D, Rossi LAllergology International2008
  2. Moreira P, Gangl K, Vieira FA, Ynoue L, Linhart B, Flicker S, Fiebig H, Swoboda I, Focke-tejkl M, Taketomi E, Valenta R, Niederberger VPLoS ONE2015
  3. Xu Y, Guan K, Sha L, Zhang J, Niu Y, Yin J, Wang LJournal of Asthma and Allergy2021
  4. Li JD, Gu J, Xu Y, Cui L, Li L, Wang Z, Yin J, Guan KThe World Allergy Organization Journal2022